ALEXION PHARMACEUTICALS, INC. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2020 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Payment of Exercise | F | 85.43 | 3,202 | 273,547 | 190,658 | 193.9 K to 190.7 K (-1.65 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 83.14 | 14,731 | 1,224,797 | 7,841,556 | 7.8 M to 7.8 M (+0.19 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 83.14 | 1,331 | 110,665 | 994,296 | 993 K to 994.3 K (+0.13 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 82.92 | 1,321 | 109,537 | 7,826,825 | 7.8 M to 7.8 M (+0.02 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 82.92 | 119 | 9,867 | 992,965 | 992.8 K to 993 K (+0.01 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 82.13 | 15,928 | 1,308,149 | 7,825,504 | 7.8 M to 7.8 M (+0.20 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 82.13 | 1,439 | 118,183 | 992,846 | 991.4 K to 992.8 K (+0.15 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 81.79 | 25,640 | 2,097,003 | 7,809,576 | 7.8 M to 7.8 M (+0.33 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 81.79 | 2,314 | 189,254 | 991,407 | 989.1 K to 991.4 K (+0.23 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 81.47 | 4,203 | 342,438 | 7,783,936 | 7.8 M to 7.8 M (+0.05 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 81.47 | 380 | 30,960 | 989,093 | 988.7 K to 989.1 K (+0.04 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 81.09 | 12,815 | 1,039,177 | 7,779,733 | 7.8 M to 7.8 M (+0.16 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 81.09 | 1,158 | 93,903 | 988,713 | 987.6 K to 988.7 K (+0.12 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 80.91 | 3,298 | 266,845 | 7,766,918 | 7.8 M to 7.8 M (+0.04 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 80.91 | 298 | 24,112 | 987,555 | 987.3 K to 987.6 K (+0.03 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.87 | 10,285 | 821,429 | 7,763,620 | 7.8 M to 7.8 M (+0.13 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.87 | 929 | 74,196 | 987,257 | 986.3 K to 987.3 K (+0.09 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.72 | 26,022 | 2,074,362 | 7,753,335 | 7.7 M to 7.8 M (+0.34 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.72 | 2,351 | 187,412 | 986,328 | 984 K to 986.3 K (+0.24 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.29 | 2,888 | 228,980 | 7,727,313 | 7.7 M to 7.7 M (+0.04 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.29 | 261 | 20,694 | 983,977 | 983.7 K to 984 K (+0.03 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.16 | 4,191 | 331,760 | 7,724,425 | 7.7 M to 7.7 M (+0.05 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.16 | 379 | 30,002 | 983,716 | 983.3 K to 983.7 K (+0.04 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 78.66 | 565 | 44,443 | 7,720,234 | 7.7 M to 7.7 M (+0.01 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 78.66 | 51 | 4,012 | 983,337 | 983.3 K to 983.3 K (+0.01 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 76.67 | 65,505 | 5,022,445 | 7,719,669 | 7.7 M to 7.7 M (+0.86 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 76.67 | 5,917 | 453,672 | 983,286 | 977.4 K to 983.3 K (+0.61 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 76.10 | 27,866 | 2,120,480 | 7,654,164 | 7.6 M to 7.7 M (+0.37 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 76.10 | 2,517 | 191,533 | 977,369 | 974.9 K to 977.4 K (+0.26 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.77 | 62,129 | 4,955,720 | 7,626,298 | 7.6 M to 7.6 M (+0.82 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.77 | 5,612 | 447,641 | 974,852 | 969.2 K to 974.9 K (+0.58 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.14 | 133,042 | 10,529,170 | 7,564,169 | 7.4 M to 7.6 M (+1.79 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 79.14 | 12,017 | 951,046 | 969,240 | 957.2 K to 969.2 K (+1.26 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 77.94 | 7,612 | 593,260 | 7,431,127 | 7.4 M to 7.4 M (+0.10 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 77.94 | 688 | 53,621 | 957,223 | 956.5 K to 957.2 K (+0.07 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 77.89 | 8,309 | 647,203 | 7,423,515 | 7.4 M to 7.4 M (+0.11 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 77.89 | 750 | 58,419 | 956,535 | 955.8 K to 956.5 K (+0.08 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 75.66 | 32,228 | 2,438,422 | 7,415,206 | 7.4 M to 7.4 M (+0.44 %) |
| Mar 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 75.66 | 2,911 | 220,251 | 955,785 | 952.9 K to 955.8 K (+0.31 %) |
| Mar 02 2020 | ALXN | ALEXION PHARMACEUT ... | Bazarko Daniel | SVP, Controller, CA ... | Payment of Exercise | F | 92.97 | 216 | 20,082 | 21,283 | 21.5 K to 21.3 K (-1.00 %) |